Skip to main content

Atopic Dermatitis Has Large Impact on Sexual Function Among Women

Medically reviewed by Carmen Pope, BPharm. Last updated on July 29, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, July 29, 2024 -- Most women with atopic dermatitis have impairment in sexual function, and about half consider that atopic dermatitis may influence their reproductive desire, according to a study published online June 11 in Acta Dermato-Venereologica.

Juan-Angel Rodriguez-Pozo, from the Virgen de las Nieves University Hospital in Granada, Spain, and colleagues examined the impact of atopic dermatitis on sexual function and reproductive wishes among women in a cross-sectional study conducted from February to March 2022. A total of 102 women with atopic dermatitis were recruited through online questionnaires.

The researchers found that 68.6 percent of the women noted impairment in sexual function, especially those with more severe disease and those with genital and gluteal involvement. About half (51 percent) of the women considered that atopic dermatitis may influence their gestational desire, especially those with gluteal involvement.

"Atopic dermatitis affects quality of life, sexuality, and gestational desire. Controllable factors such as the severity and extension of the symptoms enhance this impact. Despite all of this, patients scarcely consult on the issue with a dermatologist," the authors write. "Given this situation, an effort needs to be made by dermatologists to be concerned and to approach patients with atopic dermatitis in a more holistic way, emphasizing psychological and social aspects such as sexuality and reproductive desires."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

Read this next

Recent Decades Saw Rise in Sedative, Hypnotic, Anxiolytic Use Disorders

FRIDAY, Jan. 24, 2025 -- Diagnoses of sedative, hypnotic, or anxiolytic use disorders (SHA-UD) increased threefold to fivefold between 2001 and 2019 for adolescent and young adult...

Trump Issues Executive Order Withdrawing U.S. From WHO

WEDNESDAY, Jan. 22, 2025 -- In one of his first presidential actions on Monday, President Trump issued an executive order withdrawing the United States from the World Health...

Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis

WEDNESDAY, Jan. 22, 2025 -- Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema, desquamation, dryness, and oozing...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.